The first meeting of the Empowered Committee for COVID-19 Response was held on Saturday.
The meeting was co-chaired by Dr. Vinod Paul, Member NITI-Aayog and Professor K. Vijay Raghavan, Principal Scientific Advisor to Government of India.
The Committee was constituted to co-ordinate, amongst science agencies, scientists and regulatory bodies, and take speedy decisions on R & D to implementation related to the SARS-Cov-2 virus and the COVID-19 disease was held on March 21, 2020.
According to an official release, Indian research institutions and organizations are directed for speedy implementation of solutions related to COVID-19.
"National research labs (defined as labs of DBT/DST/CSIR/DRDO/DAE for this directive) are permitted to carry out clinical testing for COVID19 based on self-assessment and willingness to follow established protocols and all applicable reporting regulations as defined by the DHR/ICMR," it said.
The national research labs are permitted to access samples for COVID19 - related research from any government-approved clinical testing site or access clinical samples received by them for testing, subject to ethical approval for such research.
"Results from such research are required to be expeditiously shared in open formats to maximise the impact of research. Clinical care agencies are directed to enrich the open dataset by providing de-identified clinical data," read the release.
"Labs with BSL-3 or BSL-3+ facilities, with DBT/DST/CSIR/DRDO/DAE, are permitted to culture the virus and serve as additional testing and validation sites for research, based on self-assessment of BSL-3 facilities and willingness to follow established protocols as defined by the DHF2/ICMR. They may further share reagents and facilities with other national labs to ensure maximum effort for rapid solutions," the release said.
"Hospitals (Centre, State and private) to cooperate with national labs for clinical sample collection where there is an ethical approval in place, subject to capacity for such work and ability to follow established protocols," it said further.
The total number of positive cases of coronavirus has climbed to 283, said the Union Ministry of Health and Family Welfare on Saturday.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
